38.00Open38.00Pre Close0 Volume1 Open Interest40.00Strike Price0.00Turnover155.16%IV-9.58%PremiumDec 20, 2024Expiry Date46.26Intrinsic Value100Multiplier28DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9778Delta0.0014Gamma1.85Leverage Ratio-0.0388Theta0.0288Rho1.80Eff Leverage0.0126Vega
Dave Inc Stock Discussion
📊⚡️📊
thought I commented on this one already, but I've had it since April.
Similar to $Dave Inc (DAVE.US)$ , they are a competitive fintech company.
Now if Chime would go public, it would be a trifecta
Buy the dip! My initial position is $34.3 but I added more at $37.83.
If the pullback gains power I want to add alot more next time.
The tech sector, specifically semiconductors and Ai/crypto companies, aren't going anywhere. NVDA isn't going to just shrug their shoulders and give up tomorrow.
So long as you have researched and relied on financials, I think it will all come back and probably stronger than ever.
In the meantime, I've added to a couple of "defense" stocks:
$ADMA Biologics (ADMA.US)$ : 58.8% U...
$Dave Inc (DAVE.US)$
PT $41+ SL $27
$Desktop Metal (DM.US)$
LT PT: $17+
$Hims & Hers Health (HIMS.US)$
LT PT: $39.27+
$Intel (INTC.US)$
PT: $50 SL: $25
Medium duration, 14-30 days min.
A quick recap for the month ending April 30, 2024.
Ten stocks with >300% YTD
$Swvl Holdings (SWVL.US)$718.40%
$Root Inc (ROOT.US)$564.60%
$Elevation Oncology (ELEV.US)$561.08%
$JanOne (JAN.US)$554.05%
$GeneDx Holdings (WGS.US)$520.71%
$Corbus Pharmaceuticals (CRBP.US)$513.25%
$AGBA Group (AGBA.US)$482.90%
$Janux Therapeutics (JANX.US)$431.22%
$Dave Inc (DAVE.US)$4...
No comment yet